Jadhav K - Search Results

1

Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis.

Xu J, Li Y, Chen WD, Xu Y, Yin L, Ge X, Jadhav K, Adorini L, Zhang Y. Xu J, et al. Among authors: jadhav k. Hepatology. 2014 May;59(5):1761-1771. doi: 10.1002/hep.26714. Epub 2014 Apr 1. Hepatology. 2014. PMID: 24038130 Free PMC article.

2

Bile acid receptors in non-alcoholic fatty liver disease.

Li Y, Jadhav K, Zhang Y. Li Y, et al. Among authors: jadhav k. Biochem Pharmacol. 2013 Dec 1;86(11):1517-24. doi: 10.1016/j.bcp.2013.08.015. Epub 2013 Aug 26. Biochem Pharmacol. 2013. PMID: 23988487 Free PMC article. Review.

3

Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.

Li Y, Zalzala M, Jadhav K, Xu Y, Kasumov T, Yin L, Zhang Y. Li Y, et al. Among authors: jadhav k. Hepatology. 2016 Jun;63(6):1860-74. doi: 10.1002/hep.28472. Epub 2016 Mar 15. Hepatology. 2016. PMID: 26806650 Free PMC article.

4

Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury.

Xu J, Xu Y, Li Y, Jadhav K, You M, Yin L, Zhang Y. Xu J, et al. Among authors: jadhav k. Sci Rep. 2016 Apr 14;6:24277. doi: 10.1038/srep24277. Sci Rep. 2016. PMID: 27075303 Free PMC article.

5

Activating transcription factor 3 in immune response and metabolic regulation.

Jadhav K, Zhang Y. Jadhav K, et al. Liver Res. 2017 Sep;1(2):96-102. doi: 10.1016/j.livres.2017.08.001. Epub 2017 Aug 15. Liver Res. 2017. PMID: 29242753 Free PMC article.

6

Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.

Jadhav K, Xu Y, Xu Y, Li Y, Xu J, Zhu Y, Adorini L, Lee YK, Kasumov T, Yin L, Zhang Y. Jadhav K, et al. Mol Metab. 2018 Mar;9:131-140. doi: 10.1016/j.molmet.2018.01.005. Epub 2018 Jan 11. Mol Metab. 2018. PMID: 29361497 Free PMC article.

7

Lipocalin-2 Protects Against Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes.

Xu Y, Zhu Y, Jadhav K, Li Y, Sun H, Yin L, Kasumov T, Chen X, Zhang Y. Xu Y, et al. Among authors: jadhav k. Hepatol Commun. 2019 Mar 25;3(6):763-775. doi: 10.1002/hep4.1341. eCollection 2019 Jun. Hepatol Commun. 2019. PMID: 31168511 Free PMC article.

8

Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis.

Li Y, Xu Y, Jadhav K, Zhu Y, Yin L, Zhang Y. Li Y, et al. Among authors: jadhav k. Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1574-1587. doi: 10.1161/ATVBAHA.119.312610. Epub 2019 Jul 11. Arterioscler Thromb Vasc Biol. 2019. PMID: 31291759 Free PMC article.

9

Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.

Xu Y, Li Y, Jadhav K, Pan X, Zhu Y, Hu S, Chen S, Chen L, Tang Y, Wang HH, Yang L, Wang DQ, Yin L, Zhang Y. Xu Y, et al. Among authors: jadhav k. Nat Metab. 2021 Jan;3(1):59-74. doi: 10.1038/s42255-020-00331-1. Epub 2021 Jan 18. Nat Metab. 2021. PMID: 33462514 Free PMC article.

10

Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4α.

Xu Y, Hu S, Jadhav K, Zhu Y, Pan X, Bawa FC, Yin L, Zhang Y. Xu Y, et al. Among authors: jadhav k. Diabetes. 2021 Nov;70(11):2506-2517. doi: 10.2337/db21-0181. Epub 2021 Sep 2. Diabetes. 2021. PMID: 34475098 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters